Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 12(1): 1038, 2022 01 20.
Article in English | MEDLINE | ID: mdl-35058518

ABSTRACT

Assessment of forest ecosystems and their services is seen as a key action for the advancement of biodiversity objectives, and to inform the development and implementation of related policies and planning. The Azorean forest is important for timber production, the protection of soil and water resources, and for its recreational and aesthetic value. However, its role in carbon accumulation has not been fully addressed. We assessed plant diversity, forest structure and carbon stocks in a gradient of three forest types (Natural Forest-NF; Exotic Woodland-EW and Production Forest-PF) in three of the Azores islands. We used biodiversity indices and found that NF harbored the highest plant diversity levels and PF the lowest. Diversity levels were lower for structural than for taxonomic data, particularly for PF. The highest tree carbon stock was found at EW in one of the islands, while PF consistently exhibited relatively high tree carbon stocks in the three islands. The largest soil carbon stocks were found at EW, while leaf litter carbon stocks were higher at PF. We concluded that NF play a fundamental role as plant diversity hotspots but have lower relevance as carbon stocks what might be associated with montane environmental conditions. PFs provide economic assets and act as carbon sinks, while EWs play a major role as carbon sinks in soil, but also at tree level in the oldest forests.

2.
Mar Pollut Bull ; 101(2): 575-82, 2015 Dec 30.
Article in English | MEDLINE | ID: mdl-26515994

ABSTRACT

Marine debris is widely recognised as a global environmental problem. This study assesses density, type, and temporal trends of marine debris in two sandy beaches of Faial Island (Azores, NE-Atlantic). During seven months (six days per month) the beaches were surveyed by performing 10 random transects at each site. Recorded items within the range 2-30 cm were organised into seven categories. Densities of total debris varied from 0 to 1.940 items m(-2), with plastics dominating both areas. Both beaches, presented the highest debris abundance in February, most probably related to prevailing winds and swell. Location and/or time of year also seemed to influence the type of debris present. These findings provide new insights into debris accumulation rates in the Azores, where no previous studies were made. It also confirms the global trend of increased plastics accumulation on shorelines, highlighting the need for further research in remote islands.


Subject(s)
Plastics/analysis , Water Pollutants/analysis , Azores , Bathing Beaches , Environmental Monitoring , Water Pollutants, Chemical/analysis
3.
Endocrinology ; 148(9): 4136-46, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17495006

ABSTRACT

Recently, we synthesized and characterized the first selective V(1b) vasopressin (VP)/oxytocin receptor agonist, d[Cha(4)]arginine vasopressin. However, this agonist was only selective for the human receptors. We thus decided to design a selective V(1b) agonist for the rodent species. We started from previous observations showing that modifying [deamino(1),Arg(8)]VP in positions 4 and 8 altered the rat VP/oxytocin receptor selectivity. We synthesized a series of 13 [deamino(1),Arg(8)]VP analogs modified in positions 4 and 8. Among them, one seemed very promising, d[Leu(4), Lys(8)]VP. In this paper, we describe its pharmacological and physiological properties. This analog exhibited a nanomolar affinity for the rat, human, and mouse V(1b) VP receptors and a strong V(1b) selectivity for the rat species. On AtT20 cells stably transfected with the rat V(1b) receptor, d[Leu(4), Lys(8)]VP behaved as a full agonist on both phospholipase C and MAPK assays. Additional experiments revealed its ability to induce the internalization of enhanced green fluorescent protein-tagged human and mouse V(1b) receptors as expected for a full agonist. Additional physiological experiments were performed to further confirm the selectivity of this peptide. Its antidiuretic, vasopressor, and in vitro oxytocic activities were weak compared with those of VP. In contrast, used at low doses, its efficiency to stimulate adrenocorticotropin or insulin release from mouse pituitary or perfused rat pancreas, respectively, was similar to that obtained with VP. In conclusion, d[Leu(4), Lys(8)]VP is the first selective agonist available for the rat V(1b) VP receptor. It will allow a better understanding of V(1b) receptor-mediated effects in rodents.


Subject(s)
Lypressin/analogs & derivatives , Receptors, Oxytocin/agonists , Receptors, Vasopressin/agonists , Adenylyl Cyclases/metabolism , Animals , CHO Cells , Cricetinae , Cricetulus , Female , Humans , Kidney/drug effects , Kidney/physiology , Lactation , Liver/drug effects , Liver/physiology , Lypressin/chemical synthesis , Lypressin/pharmacology , Mammary Glands, Animal/drug effects , Mammary Glands, Animal/physiology , Mice , Pituitary Gland, Anterior/drug effects , Pituitary Gland, Anterior/physiology , Rats , Rats, Wistar , Receptors, Oxytocin/drug effects , Receptors, Oxytocin/genetics , Recombinant Proteins/agonists , Recombinant Proteins/drug effects , Transfection
4.
J Med Chem ; 50(4): 835-47, 2007 Feb 22.
Article in English | MEDLINE | ID: mdl-17300166

ABSTRACT

The neurohypophyseal peptides arginine vasopressin (AVP) and oxytocin (OT) mediate a wide variety of peripheral and central physiological and behavioral effects by acting on four different G-protein coupled receptors, termed V1a (vascular), V1b (pituitary), V2 (renal), and OT (uterine). We recently reported that d[Cha4]AVP (A), d[Leu4]AVP (B), d[Orn4]AVP (C), and d[Arg4]AVP (D) have high affinity and are selective agonists for the human V1b receptor. However, peptides A-D were subsequently shown to be potent antidiuretic agonists in the rat and are, thus, not selective V1b agonists in the rat. Peptides A-D served as leads for the studies reported here. They were modified at position 8 by Lys, ornithine (Orn), diaminobutyric acid (Dab), and diaminopropionic acid (Dap) to give d[Cha4,Lys8]VP (1), d[Cha4,Orn8]VP (2), d[Cha4,Dab8]VP (3), d[Cha4,Dap8]VP (4), d[Leu4,Lys8]VP (5), d[Leu4,Orn8]VP (6), d[Leu4,Dab8]VP (7), d[Leu4,Dap8]VP (8), d[Orn4,Lys8]VP (9), d[Orn4,Orn8]VP (10), d[Arg4,Lys8]VP (11), d[Arg4,Orn8]VP (12), and d[Arg4,Dab8]VP (13). All peptides were synthesized by the Merrifield solid-phase method. Their binding and functional properties were evaluated in rat AVP V1a, V1b, and V2 receptors and on the rat OT receptor expressed either in native tissues or in stably transfected cells. They were also examined in rat vasopressor, antidiuretic, and in in vitro (no Mg++) oxytocic assays. Functional studies performed on chinese hamster ovary cells expressing the different AVP/OT receptors confirm that d[Cha4,Lys8]VP (1), d[Cha4,Dab8]VP (3), d[Leu4,Lys8]VP (5), and d[Leu4,Dap8]VP (8) are the first selective agonists for the rat V1b receptor. These selective V1b agonists are promising new tools for studies of the role of the V1b receptor in the rat.


Subject(s)
Arginine Vasopressin/analogs & derivatives , Arginine Vasopressin/chemical synthesis , Oligopeptides/chemical synthesis , Peptides, Cyclic/chemical synthesis , Receptors, Vasopressin/agonists , Adenylyl Cyclases/metabolism , Animals , Antidiuretic Agents/pharmacology , Arginine Vasopressin/pharmacology , Cell Line , Cricetinae , Cricetulus , Drug Design , In Vitro Techniques , Inositol Phosphates/biosynthesis , Oligopeptides/pharmacology , Oxytocics/pharmacology , Peptides, Cyclic/pharmacology , Protein Isoforms/agonists , Radioligand Assay , Rats , Receptors, Oxytocin/agonists , Structure-Activity Relationship , Vasoconstrictor Agents/pharmacology
5.
J Pept Sci ; 12(3): 190-8, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16130178

ABSTRACT

Arginine vasopressin (AVP) mediates a wide variety of biological actions by acting on three distinct G-protein coupled receptors, termed V(1a) (vascular), V(1b) (pituitary) and V(2) (renal). It also binds to the oxytocin (OT) receptor. As part of a program aimed at the design of selective agonists for the human V(1b) receptor, we recently reported the human V(1b), V(1a), V(2) and OT receptor affinities of the following position 4 substituted analogues of [deamino-Cys(1)] arginine vasopressin (dAVP)-(1) d[Leu(4)]AVP, (2) d[Orn(4)]AVP, (3) d[Lys(4)]AVP, (4) d[Har(4)]AVP, (5) d[Arg(4)]AVP, (6) d[Val(4)]AVP, (7) d[Ala(4)]AVP, (8) d[Abu(4)]AVP, (9) d[Nva(4)]AVP, (10) d[Nle(4)]AVP, (11) d[Ile(4)]AVP, (12) d[Phe(4)]AVP, (13) d[Asn(4)]AVP, (14) d[Thr(4)]AVP: (15) d[Dap(4)]AVP. With the exception of Nos. 7 and 12, all peptides exhibit very high affinities for the human V(1b) receptor. Furthermore, peptides 1-4 exhibit high selectivities for the human V(1b) receptor with respect to the V(1a), V(2) and OT receptors and, with d[Cha(4)]AVP, in functional tests, are the first high affinity selective agonists for the human V(1b) receptor (Cheng LL et al., J. Med. Chem. 47: 2375-2388, 2004). We report here the pharmacological properties of peptides 1-4, 5 (from a resynthesis), 7, 9-13, 15 in rat bioassays (antidiuretic, vasopressor and oxytocic) (in vitro: no Mg(++)) with those previously reported for peptides 5, 6, 8, 14. We also report the rat V(1b), V(1a), V(2) and OT receptor affinities of peptides 1-5 and the rat V(2) receptor affinities for peptides: 7-15.The antidiuretic activities in units/mg of peptides 1-15, are: 1=378; 2=260; 3=35; 4=505; 5=748; 6=1150; 7=841; 8=1020; 9=877; 10=1141; 11=819, 12=110; 13=996; 14=758; 15=1053. Peptides 1-4 exhibit respectively the following rat and human (in brackets) V(2) receptor affinities: 1=3.1 nm (245 nm); 2=3.4 nm (1125 nm); 3=24.6 nm (11,170 nm); 4=0.6 nm (1386 nm). Their rat V(1b) receptor affinities are 1=0.02 nm; 2=0.45 nm; 3=9.8 nm; 4=0.32 nm. Their rat V(1a) receptor affinities are 1=1252 nm; 2=900 nm; 3=1478 nm; 4=32 nm. Their rat oxytocin (OT) receptor affinities are 1=481 nm; 2=997 nm; 3=5042 nm; 4=2996 nm. All four peptides have high affinities and selectivities for the rat V(1b) receptor with respect to the rat V(1a) and OT receptors. However, in contrast to their high selectivity for the human V(1b) receptor with respect to the human V(2) receptor, they are not selective for the V(1b) receptor with respect to the V(2) receptor in the rat. These findings confirm previous observations of profound species differences between the rat and human V(2) receptors. Peptides 1-4 are promising leads to the design of the first high affinity selective agonists for the rat V(1b) receptor.


Subject(s)
Arginine Vasopressin/analogs & derivatives , Arginine Vasopressin/chemistry , Receptors, Vasopressin/chemistry , Animals , Antidiuretic Agents/agonists , Antidiuretic Agents/chemistry , Antidiuretic Agents/pharmacology , Arginine Vasopressin/pharmacology , CHO Cells , Cricetinae , Female , Humans , Oxytocics/chemistry , Oxytocics/pharmacology , Rats , Receptors, Vasopressin/agonists , Receptors, Vasopressin/drug effects , Species Specificity , Structure-Activity Relationship , Vasoconstrictor Agents/chemistry , Vasoconstrictor Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...